Neurobiology of addiction. Toward the development of new therapies
- PMID: 10911930
- DOI: 10.1111/j.1749-6632.2000.tb06682.x
Neurobiology of addiction. Toward the development of new therapies
Abstract
Drug addiction is a chronic relapsing brain disorder characterized by neurobiological changes that lead to a compulsion to take a drug with loss of control over drug intake. The hypothesis outlined here is that knowledge of the neurochemical systems involved in the transition from drug use to the compulsive use of addiction will provide the rational basis for development of pharmacotherapies for drug addiction. Much evidence has been obtained in identifying the midbrain-basal forebrain neural elements involved in the positive reinforcing effects of drugs of abuse and more recently in the neural elements involved in the negative reinforcement associated with drug addiction. Key elements for the acute reinforcing effects of drugs of abuse include a macrostructure in the basal forebrain called the extended amygdala that contains parts of the nucleus accumbens and amgydala and involves key neurotransmitters such as dopamine, opioid peptides, serotonin, GABA, and glutamate. Withdrawal from drugs of abuse is associated with subjective symptoms of negative affect, such as dysphoria, depression, irritability and anxiety, and dysregulation of brain reward systems involving some of the same neurochemical systems implicated in the acute reinforcing effects of drugs of abuse. In addition, acute withdrawal is accompanied by recruitment of the brain stress neurotransmitter system, corticotropin-releasing factor. Animal models of craving involve not only conditioning models but also models of excessive drug intake during prolonged abstinence, post-acute withdrawal, that may reflect continued dysregulation of drug reinforcement that could lead to vulnerability to relapse and represent an important focus for pharmacotherapy. Such changes have been hypothesized to involve a change in set point for drug reward that may represent an allostatic state contributing to vulnerability to relapse and re-entry into the addiction cycle. Elucidation of the specific neuropharmacological changes contributing to this prolonged functional dysregulation will be the challenge of future research on the neurobiology of drug addiction.
Similar articles
-
Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.Psychopharmacology (Berl). 2017 May;234(9-10):1315-1332. doi: 10.1007/s00213-016-4484-6. Epub 2017 Jan 3. Psychopharmacology (Berl). 2017. PMID: 28050629 Review.
-
Review. Neurobiological mechanisms for opponent motivational processes in addiction.Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3113-23. doi: 10.1098/rstb.2008.0094. Philos Trans R Soc Lond B Biol Sci. 2008. PMID: 18653439 Free PMC article. Review.
-
Drug addiction: functional neurotoxicity of the brain reward systems.Neurotox Res. 2001 Jan;3(1):145-56. doi: 10.1007/BF03033235. Neurotox Res. 2001. PMID: 15111266
-
Neuroadaptive mechanisms of addiction: studies on the extended amygdala.Eur Neuropsychopharmacol. 2003 Dec;13(6):442-52. doi: 10.1016/j.euroneuro.2003.08.005. Eur Neuropsychopharmacol. 2003. PMID: 14636960 Review.
-
Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors.Ann N Y Acad Sci. 2001 Jun;937:1-26. doi: 10.1111/j.1749-6632.2001.tb03556.x. Ann N Y Acad Sci. 2001. PMID: 11458532 Review.
Cited by
-
An Empirical Investigation of the Three-Pathway Model and its Contribution to the Gambling Disorder Psychopathology.J Gambl Stud. 2024 May 28. doi: 10.1007/s10899-024-10316-4. Online ahead of print. J Gambl Stud. 2024. PMID: 38802627
-
Role of α1-GABAA receptors in the serotonergic dorsal raphe nucleus in models of opioid reward, anxiety, and depression.J Psychopharmacol. 2024 Feb;38(2):188-199. doi: 10.1177/02698811241227672. Epub 2024 Jan 31. J Psychopharmacol. 2024. PMID: 38293836 Free PMC article.
-
Neuronal activity of the medial prefrontal cortex, nucleus accumbens, and basolateral amygdala in conditioned taste aversion and conditioned place preference induced by different doses of morphine administrations in rats.Front Pharmacol. 2023 Jan 24;14:1062169. doi: 10.3389/fphar.2023.1062169. eCollection 2023. Front Pharmacol. 2023. PMID: 36762112 Free PMC article.
-
The Relationship of Serum Leptin and Ghrelin Levels with Craving and Withdrawal in Opioid Use Disorder.Alpha Psychiatry. 2021 Jun 28;22(4):200-205. doi: 10.5152/alphapsychiatry.2021.2056. eCollection 2021 Jul. Alpha Psychiatry. 2021. PMID: 36424933 Free PMC article.
-
Reactivating hippocampal-mediated memories during reconsolidation to disrupt fear.Nat Commun. 2022 Sep 12;13(1):4733. doi: 10.1038/s41467-022-32246-8. Nat Commun. 2022. PMID: 36096993 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical